Triamcinolona
|
Knee osteoarthritis (OA) results in the progressive loss of the articular cartilage, severe pain, and disability in the affected joint. 1–6 As the condition is chronic and nonfatal, it can significantly impact an individual’s long-term quality of life.6,7 The goals of OA management are to reduce pain, improve function, slow progression of the disease, and delay surgical intervention[1] |
Osteoartritis de rodilla conduce a una perdida progresiva de cartilago, dolor fuerte, y discapacidad de la articulación afectada. Como el estado es crónico y no mortal, puede impactar en forma importante la calidad de vida de la persona, los objetivos de manejo son reducción de dolor, mejorar la funcionalidad, y disminuir la progresión de la enfermedad, además de dilatar la intervención quirúrgica |
Modo de Uso[editar]
hexacetonido [2]
ATC[editar]
|
wikipedia:Triamcinolone_acetonide
The Use of Intralesional Steroids in a Case of Localized Pemphigus Foliaceus
Clinical spectrum and management options in Vogt-Koyanagi-Harada disease
Local Injection of Triamcinolone Acetonide: A Forgotten Aetiology of Cushing’s Syndrome
- ↑ McCormack et al 2017 Comparison of the 3 Different Injection Techniques Used in a Randomized Controlled Study Evaluating a Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) for Osteoarthritis of the Knee: A Subgroup Analysis
- ↑ http://www.farmaciasahumada.cl/fasa/MFT/PRODUCTO/P11218.HTM